News Forget double helix. ‘Quadruple helix’ DNA discovered in human cells | ScienceBlog.com In 1953, Cambridge researchers Watson and Crick published a paper describing the interweaving ‘double helix’ DNA structure – the chemical…Super UserJanuary 22, 2013
News ETC Announces AccelerateBaltimore™ Winning Companies Baltimore City’s technology incubator, ETC (Emerging Technology Center), announced today that six companies have been selected to participate in the…Super UserJanuary 21, 2013
News Washington region raises an abysmal $95 million in Q4 venture funding – Washington Business Journal Companies in Maryland, Virginia and D.C. raised a paltry $94.9 million in venture funding in the last three months of…Super UserJanuary 21, 2013
News Emergent BioSolutions, Inc., signs license agreement for flu vaccine production – Vaccine News Daily Emergent BioSolutions, Inc., recently signed a license agreement for the manufacture and sale of VaxInnate Corporation’s recombinant influenza vaccine. The…Super UserJanuary 18, 2013
News New Enterprise Associates tops list of most active VCs – Washington Business Journal Bicoastal venture titan New Enterprise Associates ranked as the most active VC firm in the country last year, according to…Super UserJanuary 17, 2013
News Maryland budget reflects improving economy – baltimoresun.com Gov. Martin O'Malley released a $37 billion spending plan Wednesday that for the first time in recent years contains no…Super UserJanuary 17, 2013
News Blueprint Health’s new class shows there are still plenty of new ideas in the digital health pipeline – MedCity News Another day, another class of digital health startups. That’s how it feels sometimes, with so many accelerators working with dozens…Super UserJanuary 17, 2013
News GSK seeks FDA approval for new GLP-1 agonist British healthcare firm GlaxoSmithKline has filed for US regulatory approval of its new type 2 diabetes drug albiglutide, which belongs…Super UserJanuary 17, 2013
News Peter Greenleaf steps down as MedImmune president, Bahija Jallal chosen as replacement – Capital Business Blog – The Washington Post Peter Greenleaf is stepping down down as president of Gaithersburg-based biotechnology giant MedImmune, according to a company spokesman, to take…Super UserJanuary 17, 2013
News Bahija Jallal to replace Peter Greenleaf as head of MedImmune – Baltimore Business Journal MedImmune executive Bahija Jallal will be the new chief of the Gaithersburg biotech under a leadership shuffle by parent company…Super UserJanuary 16, 2013